BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
30 hedge funds and large institutions have $38.5M invested in Biolase, Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
30
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.02M | |
| 2 | +$291K | |
| 3 | +$101K | |
| 4 |
Millennium Management
New York
|
+$62.4K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$23K |
Top Sellers
| 1 | -$253K | |
| 2 | -$216K | |
| 3 | -$83K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$62K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$47.1K |